Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 68217N105 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Flagship V VentureLabs Rx Fund, L.P.
13D/A
|
52.8% |
2/5/2025
Event 2/3/2025
|
||
| Flagship V VentureLabs Rx Fund, L.P. | 2.0% | |||
| Flagship Ventures Fund V, L.P. | 10.6% | |||
| Flagship Ventures Fund V General Partner LLC | 12.6% | |||
| Flagship Pioneering Fund VI, L.P. | 15.6% | |||
| Flagship Pioneering Fund VI General Partner LLC | 15.6% | |||
| Nutritional Health LTP Fund, L.P. | 1.8% | |||
| Nutritional Health LTP Fund General Partner LLC | 1.8% | |||
| Flagship Pioneering Special Opportunities Fund II, L.P. | 13.6% | |||
| Flagship Pioneering Special Opportunities Fund II General Partner LLC | 13.6% | |||
| FPN, L.P. | 2.9% | |||
| FPN General Partner LLC | 2.9% | |||
| Flagship VentureLabs V, LLC | 4.0% | |||
| Flagship VentureLabs V Manager LLC | 4.0% | |||
| Flagship Pioneering Fund VII, L.P. | 2.4% | |||
| Flagship Pioneering Fund VII General Partner LLC | 2.4% | |||
| Flagship Pioneering, Inc. | 40.2% | |||
| Noubar Afeyan | 52.8% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (2) | ||||
|
Flagship Ventures Fund V, L.P.
13D/A
Amended
by Flagship V VentureLabs Rx Fund, L.P.
on 2/5/2025
|
52.8% |
12/31/2024
Event 12/29/2024
|
||
| Flagship V VentureLabs Rx Fund, L.P. | 2.0% | |||
| Flagship Ventures Fund V, L.P. | 10.6% | |||
| Flagship Ventures Fund V General Partner LLC | 12.6% | |||
| Flagship Pioneering Fund VI, L.P. | 15.6% | |||
| Flagship Pioneering Fund VI General Partner LLC | 1.8% | |||
| Nutritional Health LTP Fund, L.P. | 1.8% | |||
| Nutritional Health LTP Fund General Partner LLC | 1.8% | |||
| Flagship Pioneering Special Opportunities Fund II, L.P. | 13.6% | |||
| Flagship Pioneering Special Opportunities Fund II General Partner LLC | 13.6% | |||
| FPN, L.P. | 2.9% | |||
| FPN General Partner LLC | 2.9% | |||
| Flagship VentureLabs V, LLC | 4.0% | |||
| Flagship VentureLabs V Manager LLC | 4.0% | |||
| Flagship Pioneering Fund VII, L.P. | 2.4% | |||
| Flagship Pioneering Fund VII General Partner LLC | 2.4% | |||
| Flagship Pioneering, Inc. | 40.2% | |||
| Noubar Afeyan | 52.8% | |||
|
FMR LLC
13G/A
|
0% |
3/7/2025
Event 2/28/2025
|
||
| FMR LLC | 0% | |||
| Abigail P. Johnson | 0% | |||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q2 | 1 | 1.00 | $0 |
| 2026 Q1 | 1 | 1.00 | $0 |
| 2025 Q4 | 1 | 1.00 | $0 |
| 2025 Q3 | 1 | 1.00 | $0 |
| 2025 Q2 | 1 | 1.00 | $0 |
| 2025 Q1 | 4 | 19.6 k | $2.50 k |
| 2024 Q4 | 57 | 47.3 M | $35.3 M |
| 2024 Q3 | 59 | 48.3 M | $59.0 M |
| 2024 Q2 | 75 | 50.7 M | $105 M |
| 2024 Q1 | 78 | 51.4 M | $188 M |
| 2023 Q4 | 69 | 50.4 M | $152 M |
| 2023 Q3 | 63 | 50.9 M | $109 M |
| 2023 Q2 | 64 | 51.1 M | $286 M |
| 2023 Q1 | 62 | 50.2 M | $303 M |
| 2022 Q4 | 56 | 42.7 M | $390 M |
| 2022 Q3 | 49 | 42.6 M | $231 M |
| 2022 Q2 | 49 | 42.5 M | $161 M |
| 2022 Q1 | 53 | 43.5 M | $272 M |
| 2021 Q4 | 47 | 42.5 M | $481 M |
| 2021 Q3 | 44 | 41.2 M | $773 M |